Navigation Links
Human Genome Sciences Announces Third Quarter 2007 Financial Results and Key Developments
Date:11/1/2007

priority, and we have made excellent progress through a combination of increased revenues, clinical development cost-sharing and spending controls."

THIRD QUARTER 2007 FINANCIAL RESULTS

For the quarter ended September 30, 2007, HGS reported increased revenues of $11.1 million, compared with revenues of $6.7 million for the same period in 2006. This included $7.8 million in revenue recognized from the Albuferon agreement with Novartis, and $1.6 million in revenue recognized from the LymphoStat-B agreement with GlaxoSmithKline (GSK). The Company reported a net loss of $67.3 million ($0.50 per share) for the quarter ended September 30, 2007, compared with a net loss for the third quarter of 2006 of $60.8 million ($0.46 per share).

For the first nine months of 2007, HGS reported increased revenues of $29.3 million compared with revenues of $15.7 million for the same period of the previous year. Revenues for the first nine months included $19.2 million in revenue recognized from the Albuferon agreement with Novartis and $4.9 million in revenue recognized from the LymphoStat-B agreement with GSK. The Company reported a net loss of $169.6 million ($1.26 per share) for the nine months ended September 30, 2007, compared with a net loss of $184.2 million ($1.40 per share) for the same period of the previous year.

As of September 30, 2007, cash and investments totaled $688.8 million, of which $620.0 million is unrestricted and available for operations. This compares with cash and investments totaling $763.1 million, of which $701.9 million was unrestricted and available for operations, as of December 31, 2006.

HIGHLIGHTS OF RECENT PROGRESS

Albuferon: Enrollment of Phase 3 Trials Completed Two Months Ahead of Schedule

In a separate press release issued this morning, HGS announced that it has completed enrollment two months ahead of schedule in ACHIEVE 2/3, the second of two pivotal Phase 3 trials of Albuferon (albinterferon alfa-2b) in
'/>"/>

SOURCE Human Genome Sciences, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related biology technology :

1. Human Primary Preadipocytes and Differentiated Adipocytes
2. Low Abundance cDNA Cloned Using Stratagenes Human Universal cDNA Library
3. Control RT-PCR Primers for Human Gene Transcripts with Varying Abundance
4. New Mammalian Expression Vectors Employ Stable, High-Level Fluorescence Humanized Renilla GFP Reporter
5. Human Universal cDNA Library Array I
6. Map and Link Human Genetic Disorders with SSLP Analysis
7. RT-PCR Primer Sets for Human and Mouse Mismatch Repair Genes
8. Transfection of Green Fluorescent Protein into Human Adrenalcarcinoma Cells
9. Fluorescence-Based Single-Tube Assays to Rapidly Detect Human Gene Mutations
10. Improve Lipid- or Calcium Phosphate-Mediated Transfection of Human Dermal Fibroblasts
11. Sequence-Validated and Expression-Tested Human cDNA in a Dual Expression Vector
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/27/2015)... 2015 A paper published today, " ... " in Science Translational Medicine, demonstrates ... reduce the risk associated with investing in the ... levels of funding for developing so-called "orphan" drugs. ... collaboration between scientists at the National Center for ...
(Date:2/27/2015)... 27, 2015 Immunovaccine Inc. (“Immunovaccine”) ... company, today announced that the U.S. Food and ... Track designation and Phase I clinical trials of ... the mutual co-development agreement signed with Gilead Life ... designation for the DPX-Survivac. , “We have been ...
(Date:2/27/2015)... ADELAIDE, Australia , Feb. 27, 2015 ... data from the DisrupTOR-1 trial of BNC105 in patients ... Symposium in Orlando, Florida . The ... of the City of Hope Comprehensive Cancer Center ... presentation. The new data identifies Ferritin ...
(Date:2/27/2015)... 2015 FamilyFarms Group is pleased to ... State Line Farms, received the 2015 Tomorrow’s Top Producer ... the age of 35, who has demonstrated excellence in ... to win the Tomorrow's Top Producer Horizon Award. Every ... Top Producer Award and learning from their experiences. It ...
Breaking Biology Technology:New Financing Technique May Hold Key to Unlocking Funding for Rare Diseases 2New Financing Technique May Hold Key to Unlocking Funding for Rare Diseases 3New Financing Technique May Hold Key to Unlocking Funding for Rare Diseases 4Immunovaccine Inc. (TSX: IMV) receives Fast Track and Phase I trial approval for Ebola and Anthrax vaccine programs, signs co-development agreement with Gilead Sciences 2Immunovaccine Inc. (TSX: IMV) receives Fast Track and Phase I trial approval for Ebola and Anthrax vaccine programs, signs co-development agreement with Gilead Sciences 3New BNC105 Biomarker Data to be Presented at US Cancer Conference 2New BNC105 Biomarker Data to be Presented at US Cancer Conference 3New BNC105 Biomarker Data to be Presented at US Cancer Conference 4New BNC105 Biomarker Data to be Presented at US Cancer Conference 5Matt Sims Receives the 2015 Tomorrow’s Top Producer Horizon Award 2
... Gel Cleanup Kit , , ... Kit , , , , , , ... , October 1, 2002, , , , ... gel electrophoresis is a method used to separate and analyze , DNA ...
... , , , , Jrgen ... Knig; Institute for Microbiology , and Wine Research, , ... , , , , , ... , , The isolation of microorganisms (such as bacteria or yeast) from ...
...
Cached Biology Technology:Eppendorf Perfectprep Gel Cleanup Kit 2Eppendorf Perfectprep Gel Cleanup Kit 3Eppendorf Perfectprep Gel Cleanup Kit 4Eppendorf Perfectprep Gel Cleanup Kit 5Eppendorf Perfectprep Gel Cleanup Kit 6Isolation of Microorganisms 2Isolation of Microorganisms 3
(Date:2/9/2015)...  Lintec of America recently announced an exclusive license ... macrostructures, including sheets, yarns and ribbons, developed at the ... the vast industrial resources of the global Lintec Group, ... of America is forming the Nano-Science and Technology Center ... on scaling up the manufacturing and commercialization of nano ...
(Date:2/5/2015)... --NXT-ID, Inc. (NASDAQ: NXTD and NXTDW) ... on the growing mobile commerce market, announces the launch ... part of its 2015 marketing and branding initiatives for ... consumer website for Wocketwallet.com earlier this month. ... "Our new corporate website naturally showcases our premiere consumer ...
(Date:2/5/2015)... , Jan. 28, 2015 Research and Markets ... addition of the "Global Biometrics Market (2014-2020): ... and Countries " report to their offering. ... Asia-Pacific is anticipated to overtake ... owing to increasing government spending towards IT security, ...
Breaking Biology News(10 mins):Lintec announces exclusive license to commercialize innovative carbon nanotube technology from the University of Texas at Dallas 2Lintec announces exclusive license to commercialize innovative carbon nanotube technology from the University of Texas at Dallas 3Lintec announces exclusive license to commercialize innovative carbon nanotube technology from the University of Texas at Dallas 4NXT-ID, Inc. Launches New Corporate Website As Part Of Ongoing 2015 Branding Initiatives For Wocket Smart Wallet 2NXT-ID, Inc. Launches New Corporate Website As Part Of Ongoing 2015 Branding Initiatives For Wocket Smart Wallet 3Global Biometrics Market (2014-2020): Market Forecast By Technologies, Applications, End Use, Regions and Countries 2Global Biometrics Market (2014-2020): Market Forecast By Technologies, Applications, End Use, Regions and Countries 3
... that prevents the body from using stored sugar has survived ... at the University of Florida putting scientists a step ... Called glycogen storage disease type 1A, the genetic disease ... use sugar between meals. In order to survive, children and ...
... Francisco, and collaborators at Harvard Medical School have linked ... that clears glucose out of the bloodstream, shedding light ... a cellular level. Establishing the function ... mice, has broad implications for both the future study ...
... for Cancer Research at the University of California, San ... of the contractile ring, a structure required for cell ... divide the cell may facilitate development of therapies to ... researchers show that even though both cell volume ...
Cached Biology News:UF makes gene therapy advance in severe genetic disorder 2UF makes gene therapy advance in severe genetic disorder 3UCSF discovers new glucose-regulating protein linked with diabetes 2Study may aid efforts to prevent uncontrolled cell division in cancer 2
... is obtained from non-demolished blood ... fasted donors. The donors are ... and are maintained on an ... Protein Concentration : 85 mg/ml ...
... Captiva 96-well Filter Plates are offered ... and 0.45 um depth filter plates are ... LC/MS analysis. Filtration is simple, versatile, and ... columns. The Captiva 10 um glass fiber ...
... CyScribe First-Strand cDNA Labeling System ... Kit, 50 reactions. For the generation ... cDNA.Optimized reagents are packaged together for ... optimized protocols can be used for ...
Collected from sexually mature, mixed sex, mixed breed dogs. Serum from specific breeds available by request....
Biology Products: